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Abstract
Study design Multicentre, cross-sectional study.
Objectives To identify which markers of obesity, injury characteristics and autonomic function variables are related to
cardiovascular disease (CVD) risk after spinal cord injury (SCI), and establish cut-points for detection and risk management.
Setting Eight SCI rehabilitation centres in the Netherlands.
Methods Individuals (n= 257) with a traumatic, chronic (≥10 years) SCI, with age at injury between 18 and 35 years,
completed a self-report questionnaire and a one-day visit to a rehabilitation centre for testing. Three anthropometric
measures were tested: body mass index (BMI); waist circumference (WC); and waist-to-height ratio (WHtR). Injury
characteristics included: American Spinal Injury Association impairment scale (AIS); duration of injury (DOI); and neu-
rological level of injury (LOI). Cardiovascular autonomic function was assessed from peak heart rate during maximal
exercise (HRpeak). Systolic arterial pressure (SAP) and aerobic capacity (VO2peak) were also determined. CVD risk was
calculated using the Framingham risk score (FRS).
Results All anthropometric variables were associated with FRS, with WC showing the strongest correlation (r= 0.41, p <
0.001) and greatest area under the curve (0.73) for 10-year CVD risk (%). WC, DOI, SAP, HRpeak, LOI, and VO2peak
(variable importance: 0.81, 1.0, 0.98, 0.98, 0.66, 0.68, respectively) were important predictive variables for 10-year CVD
risk in individuals with SCI.
Conclusions We confirm that WC is a simple, practical measure of CVD risk, and along with DOI and markers of
cardiovascular autonomic function, plays a role in the increased CVD risk following SCI.
Introduction
There are currently an estimated 4 million individuals living
with the devastating consequences of a spinal cord injury
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(SCI) worldwide, with an average of 750,000 new cases
each year [1]. SCI is more common in males (~76% of the
SCI population) [2]. With advances in acute care and
chronic management, the average age of individuals living
with SCI (51 years) is increasing [2], and cardiovascular
disease (CVD) is now the leading cause of morbidity and
mortality among individuals with SCI [3], similar to the
able-bodied population [4]. However, CVD is reported to
occur earlier and progress more rapidly in individuals with
SCI than in the able-bodied [5].
SCI disrupts sensory, motor, and autonomic pathways,
with higher, more complete injuries resulting in greater loss of
sensorimotor function [6] and increasing autonomic impair-
ment [7]. The impairments in autonomic function are parti-
cularly pertinent in terms of CVD risk, as disruption to
descending cardiovascular autonomic pathways impairs car-
diovascular control of blood pressure and heart rate (HR),
particularly in those with injuries at or above the sixth thoracic
vertebra (T6) [8, 9]. These high-level autonomically-complete
lesions are characterised by blood pressure instability [10],
cardiac arrhythmia [11], and an inability to increase HR
appropriately during exercise [12]. These numerous cardio-
vascular autonomic impairments have a devastating impact on
quality of life [13], are consistently rated as a priority for
improvement by individuals living with SCI [14], and are
associated with an increased risk of CVD [15–17].
The repercussions of impaired autonomic function in this
population are profound and affect multiple systems,
negatively impacting traditional CVD risk factors, while
possibly introducing new ones. Following SCI the pre-
valence of obesity is increased, likely from reduced physical
activity [18], increased sedentary time [17], and decreased
lean muscle mass [19], although alterations in metabolism
[20] and gastrointestinal function [21] may also contribute.
In those with autonomic impairment, increases in adiposity
are commonly located around the viscera [22], which has a
particularly poor prognosis in terms of CVD risk [23].
Given the high CVD burden after SCI, there is con-
siderable interest in optimising assessment tools for the
evaluation of CVD risk following injury, to ensure they are
appropriate for this population. Given the known associa-
tion between obesity and CVD risk, measures of adiposity
are common screening tools. While body mass index (BMI)
remains the ‘gold standard’ measurement for the general
population, it underestimates obesity in those with SCI [24].
From a practical standpoint, waist circumference (WC)
provides several measurement advantages in an SCI popu-
lation—eliminating the need for specialised wheelchair
scales to determine weight, and avoiding the difficulties,
brought by spasticity and contractures, of recording height
or length. In addition, WC is more strongly correlated with
visceral adipose tissue in the SCI population than BMI [22].
There are promising preliminary data supporting the use of
WC, and perhaps waist-to-height ratio (WHtR), as valid
measures of obesity-related CVD risk in individuals with
SCI [25]. However, these need to be confirmed in larger
cohorts. In addition, the impact of sex and injury char-
acteristics on obesity-related CVD and the development of
SCI-specific cut-points for obesity-related CVD are lacking.
Accordingly, we aimed to identify which metrics of
obesity, injury characteristics and cardiovascular autonomic
function variables are related to CVD risk (determined
using the Framingham risk score [FRS]) in individuals with
chronic traumatic SCI. We also aimed to establish SCI-
specific cut-points for increased CVD risk based on indi-
vidual and injury characteristics, to aid identification of
individuals “at-risk” for CVD and assist health care provi-
ders when considering risk management.
Methods
This study is part of the Dutch multicentre research pro-
gramme “Active LifestyLe Rehabilitation Interventions in
aging Spinal Cord injury (ALLRISC)”, a cross-sectional
study of individuals with long-term SCI living in the
Netherlands [26]. This study was approved by the Medical
Ethics Committee of the University Medical Center Utrecht
and the Department of Research Ethics at Simon Fraser
University. Investigations were performed in accordance
with the Declaration of Helsinki of the World Medical
Association [27]. All participants gave written informed
consent prior to participation.
Participants
Individuals using a wheelchair (hand-rim or electric) with a
traumatic, chronic (≥10 yrs) SCI with age at injury between
18–35 years were included in the study. These criteria were
applied to limit the confounding effects of age-related co-
morbidities and reduce the impact of CVD risk factors
present prior to injury.
Procedures
Study participants completed a 1-day evaluation that
included an extensive medical assessment, physical exam-
ination, oral interview and several physical tests. Two
weeks prior to the visit, participants completed a self-report
questionnaire. On the testing day, participants were asked to
fast (except for water) for 12 h prior to testing, refrain from
vigorous exercise, and ensure appropriate bladder and
bowel care was performed to minimise the likelihood of
autonomic dysreflexia (AD, hypertensive episodes triggered
by sensory stimuli arising from below the level of the
lesion) during testing in susceptible individuals.
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Personal characteristics
Age, sex, and smoking status were extracted from the self-
report questionnaire. Participant weight was determined by
weighing participants in their wheelchair on a weigh bridge,
and then subtracting the weight of the wheelchair. Partici-
pants reported their own height. BMI was calculated as
weight divided by height squared (kg · m−2). WC was
measured in cm in the supine position, at the narrowest part
of the waist after a normal expiration, using a stretch-
resistant measuring tape. This approach was used because it
is a standard approach, and because of its ease of applic-
ability to the at-home and clinical arena, while recognising
that other sites commonly used for determination of WC
provide slightly different data, particularly in women [28].
WHtR was determined by dividing the measured WC by the
self-reported height. Medication use was noted (Supple-
mentary Table 1).
Injury characteristics
Duration of injury (DOI) was extracted from the self-report
questionnaire. A physiatrist determined the neurological
level and severity of injury according to the International
Standards for Neurological Classification of SCI [6]. A
complete lesion was defined as the absence of motor and
sensory function in the sacral segments, and classified as
American Spinal Injury Association (ASIA) Impairment
Scale (AIS) grade A. AIS grades B, C, and D were classi-
fied as incomplete lesions. In addition to using neurological
level of injury (LOI) linearly (C1= 1, C2= 2, etc.), LOI
was categorised according to three groups based on the
known impact of LOI on cardiovascular autonomic path-
ways: C1–C8 levels were defined as “high” injuries
(potential loss of autonomic control of cardiac function and
key vascular beds for blood pressure control); T1–T6 levels
as “mid” injuries (potential loss of autonomic control of key
vascular beds for blood pressure control, but minimal
impairment to cardiac function); and SCI levels below T6 as
“low” injuries (largely intact cardiovascular autonomic
function).
Lipoprotein and metabolic measures
Fasting blood samples were taken to determine the lipo-
protein profile (high-density lipoprotein cholesterol [HDL-
C], low-density lipoprotein cholesterol [LDL-C] and total
cholesterol [TC]), as well as the fasting blood glucose and
glycated haemoglobin levels (HbA1C). Participants were
considered to have diabetes mellitus if their HbA1C levels
were ≥48 mmol · mol−1 or they were taking a medication
associated with the treatment of diabetes (e.g. metformin or
insulin). Standardised laboratory techniques were used.
Cardiovascular autonomic function
We evaluated the integrity of cardiovascular autonomic
function from the peak HR response (HRpeak) to graded
maximal exercise testing [13]. We also determined resting
blood pressure, which is heavily influenced by the integrity
of cardiovascular autonomic pathways after SCI. Systolic
(SAP) and diastolic (DAP) arterial pressures were recorded
using a digital sphygmomanometer while participants were
seated in their wheelchair. We determined the prevalence of
hypotension using World Health Organization (WHO) cri-
teria: for men, SAP < 110 mmHg; for women, SAP < 100
mmHg. HRpeak (Polar Electro, Kempele, Finland) and peak
oxygen uptake (VO2peak, Oxycon Delta) responses to exer-
cise were determined while participants performed a stan-
dardised graded peak wheelchair exercise test using a
manual wheelchair on a treadmill [26]. The test was pre-
ceded by 5 min of seated rest. Participants then began
manually wheeling at a speed of 2 km/h for those with
tetraplegia and 4 km/h for those with paraplegia (3 km/h
was used if the other options were too slow or too fast for
the individual). The treadmill incline was increased by
0.36° every minute until the test was terminated because of
exhaustion or inability to keep pace with the speed. The
HRpeak was determined as the highest 5 s average HR during
the test. Chronotropic incompetence (CI) was defined as a
HRpeak < 125 beats per minute (based on peak responses
observed previously in those with high-level SCI and
associated CI) [9].
Cardiovascular disease risk
We used the FRS to calculate both the 10-year [29] and 30-
year [30] CVD risk. This score utilises the following risk
factors: sex; age; smoking status; diabetes; SAP; anti-
hypertensive treatment; HDL-C; and TC. However, because
SCI can impair blood pressure regulation (particularly with
lesions above T6) such that a lower SAP in a SCI popula-
tion may not be associated with a reduced overall CVD risk
in the same way as seen in able-bodied individuals, a
neutral SAP of 120 mmHg was used when calculating the
risk score. A risk score of 10% is considered “intermediate
risk” and this was the cut-point used for classifying “at-risk”
individuals [29].
Statistical analyses
Statistical analyses were performed using SigmaPlot sta-
tistical software (version 13; Systat Software Inc., San Jose,
CA) and R (version 3.5.1, 2015). Continuous data were
tested for normality using the Shapiro–Wilk test and para-
metric or nonparametric statistics used accordingly. Corre-
lations were performed using Spearman’s rank-order tests
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(nonparametric data) or Pearson’s product moment analyses
(parametric data) to examine the relationships between
anthropometric measures, individual risk factors and 10-
year and 30-year FRS. Numeric variables included: age
(years); DOI (years); WC (cm); BMI (kg · m−2); WHtR
(cm · m−1); HbA1C (mmol · mol−1); HDL-C (mmol · L−1);
TC (mmol · L−1) and VO2peak (mL · kg
−1 · min−1). Catego-
rical variables included: sex (1=male, 2= female); pre-
sence of diabetes (0= non-diabetic, 1= diabetic); smoking
status (0= non-smoker, 1= smoker; defined as currently
smoking, having smoked within the last 5 years, or having
smoked >20 pack years in the last 15 years [31, 32]).
Several variables were incorporated in the analyses as
both numeric and categorical parameters: FRS (catego-
rical: “at-risk” FRS ≥ 10%= 1; not “at-risk” FRS < 10%=
0; numeric: risk score %); LOI (categorical: “high”= 1,
“mid”= 2, or “low”= 3; ordinal, handled as numeric:
C1= 1, C2= 2 etc); AIS (categorical: complete (A)= 1,
incomplete (B-D)= 2; ordinal, handled as numeric:
A= 1, B= 2, C= 3, D= 4); HRpeak (categorical: CI present
(HRpeak < 125 bpm)= 1, CI absent (HRpeak ≥ 125 bpm)= 0;
numeric: HRpeak bpm); SAP (categorical: normal (110–
140mmHg)= 0, abnormal (<110mmHg or >140mmHg)=
1; numeric: SAP mmHg). This approach was taken because
we felt it might be preferable clinically to use categorical
values for risk assessment, but we wanted to validate
that information contained in the linear analyses was not
being lost with this approach. Forced linear regression
models, and Akaike information criterion (AIC) model-
averaging were used to assess the impact of each variable
on the FRS. We did not include potential predictors in
the model that were incorporated in the generation of
the FRS score. Receiver operator characteristic (ROC)
curves were produced, and the area under the curve
(AUC) calculated. Cut-points were determined using the
Euclidean, Youden, and Product indices, derived from
the sensitivity and specificity values generated from ROC
analysis [33, 34]. Agreement between at least two indices
was necessary for a cut-point recommendation [33].
Unbiased recursive partitioning (URP) was employed
as an additional method to confirm variables of interest
and their cut-points. URP identifies homogenous sub-
groups from an initial heterogeneous population, creating
conditional inference trees [35]. Where sample sizes
permitted, separate analyses were conducted for male
and female participants. Sex differences were determined
using unpaired student t tests (parametric data) or
Mann–Whitney t tests (nonparametric data) and chi-
squared analyses for proportions. The level of significance
was set at p < 0.05. Continuous data are reported as
mean ± standard error unless stated otherwise; categorical
variables are reported as percentages.
Results
Participants
A total of 282 individuals participated in the study. We
were specifically interested in the effects of traumatic SCI,
so data from 257 individuals (61 females) aged 47 ± 8 (SD)
years with chronic (24 ± 9 (SD) years) traumatic SCI were
included in the analyses. Participant characteristics are
shown in Table 1. For various reasons not all data were
collected in all participants; sample sizes for each measure
are provided in Table 1. Most lesions were cervical (45%)
or thoracic (50%); 71% were motor/sensory complete and
79% had lesions that could affect cardiovascular autonomic
control (at or above T6). For the cohort as a whole, 87
individuals (38%: 82 male and 5 female) were considered
“at-risk” of CVD using the 10-year FRS, and 176 indivi-
duals (77%: 149 male and 27 female) were “at-risk” of
CVD using the 30-year FRS. Male sex was associated with
higher 10-year and 30-year FRS, and a higher prevalence of
resting hypotension and diabetes. Males also had sig-
nificantly higher WC, HbA1C and lower HDL-C. Males
had higher VO2peak, but not higher HRpeak, than females
(Table 1). Older individuals had higher 10-year (r= 0.70;
p < 0.001; n= 228) and 30-year (r= 0.64; p < 0.001;
n= 228) FRS.
Anthropometric measures and FRS
All three anthropometric measures (WC, WHtR and BMI)
were positively correlated with both the 10-year and 30-year
FRS for all participants combined, as well as for the male
cohort (Table 2). Correlations were not statistically sig-
nificant in females, in whom the sample size was much
smaller. For the group as a whole, WC had the numerically
highest correlation with both 10-year and 30-year CVD risk.
ROC curves were generated for all three anthropometric
measures and both the 10-year and 30-year FRS (Fig. 1).
The AUC for WC was significantly greater than both BMI
(p= 0.002) and WHtR (p= 0.04) for the 30-year FRS, and
greater than WHtR (p= 0.02) for the 10-year FRS. Using
the sensitivity and specificity values derived from the ROC
analysis, optimal WC cut-points for identification of “at-
risk” individuals were 97 cm and 94 cm for males, for the
10-year and 30-year FRS respectively (Supplementary
Table 2). Note that only 5 women were “at-risk” for the 10-
year FRS, and only 27 women “at-risk” for the 30-year
FRS, and accordingly the determination of the cut-point
criteria, particularly for 10-year risk, in females is not
considered reliable. The cut-point for the 30-year risk was
80 cm for females, but should be considered with caution
due to the low sample size.
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Anthropometric measures and CVD risk factors
Correlations between anthropometric measures and tradi-
tional CVD risk factors are shown in Table 3. All three
anthropometric measures were positively correlated with
age, and the presence of diabetes, and negatively correlated
with HDL-C. WC was the only anthropometric measure
significantly correlated with sex, with males having a larger
WC. BMI was also positively correlated with SAP, HbA1C
and TC.
Impact of injury characteristics on CVD risk factors
and FRS
Correlations between injury characteristics, traditional CVD
risk factors, and FRS scores are shown in Table 4. Longer
duration injuries were associated with higher SAP, greater
adiposity (WC, WHtR), an increased 10-year and 30-year
FRS, and older age (r= 0.851; p < 0.0001; n= 257).
Higher level injuries were associated with greater
impairments in cardiovascular autonomic function (lower
Table 1 Participant
characteristics.
Characteristic All n Male n Female n p value
Age (years) 47 ± 8 257 47 ± 9 196 47 ± 9 61 0.98
Duration of injury (years) 24 ± 9 257 24 ± 9 196 23 ± 9 61 0.86
Level of injury (%)
Cervical 45 114 47 93 34 21 0.07
Thoracic 50 128 47 92 59 36 0.10
Lumbar 5 14 6 11 5 3 0.77
Sacral 0 0
Motor/sensory completeness of injury (%)
Complete 71 183 70 138 75 45 0.45
Incomplete 29 73 30 58 25 15 0.45
Stratification by autonomic impairment (%)
High (C1–C8) 45 114 47 93 34 21 0.07
Mid (T1–T6) 34 88 32 63 41 25 0.20
Low (Below T6) 21 54 20 40 23 14 0.61
BMI (kg · m−2) 25 ± 5 254 26 ± 5 193 25 ± 5 61 0.21
WC (cm) 97 ± 15 239 100 ± 14 184 89 ± 14 55 <0.001
WHtR (cm · m−1) 0.54 ± 0.08 238 0.55 ± 0.08 183 0.53 ± 0.09 55 0.14
HbA1C (mmol · mol−1) 36 ± 7 209 37 ± 8 160 35 ± 4 49 0.04
Diabetes (%) 12 25 15 24 2 1 0.01
Smoking (%) 35 89 35 69 33 20 0.77
HDL-C (mmol · L−1) 1.2 ± 0.36 228 1.1 ± 0.28 172 1.5 ± 0.45 56 <0.001
TC (mmol · L−1) 4.9 ± 1 228 4.8 ± 1 172 5.1 ± 1 56 0.06
SAP (mmHg) 126 ± 26 253 125 ± 26 192 126 ± 25 61 0.78
HRpeak (bpm) 147 ± 29 156 145 ± 30 118 152 ± 26 38 0.24
VO2peak (ml · min
−1 · kg−1) 17.1 ± 6.1 160 17.8 ± 6.2 118 15.2 ± 5.4 42 0.017
Hypotension (%) 26 69 30 57 13 8 0.01
CI (%) 23 36 25 29 47 7 0.43
10-year FRS (%) 10 ± 8 227 12 ± 8 172 5 ± 4 55 <0.001
10-year increased FRS (%) 38 87 48 82 9 5 <0.001
30-year FRS (%) 23 ± 16 228 27 ± 16 172 14 ± 10 56 <0.001
30-year increased FRS (%) 77 176 87 149 50 27 <0.001
Data are presented as mean ± standard deviation or percentages. Note that not all measures were obtained in
all participants. Bold text denotes significant differences (p < 0.05) between males and females, with
significance indicated in the last column (p value).
BMI body mass index, WC waist circumference, WHtR waist-height ratio, HbA1C glycated haemoglobin,
HDL-C high-density lipoprotein cholesterol, TC total cholesterol, SAP systolic arterial pressure, HRpeak
maximum heart rate at peak aerobic capacity, VO2peak peak oxygen uptake during maximal exercise, CI
chronotropic incompetence, FRS Framingham risk score, n sample size.
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HRpeak), as well as a lower SAP and HDL-C. Those with
higher LOI were also less likely to smoke and tended to
have a higher WC (p= 0.056). LOI was not significantly
correlated with the 10-year or 30-year FRS.
Lower AIS scores (more complete lesions) were asso-
ciated with higher HRpeak, SAP, and prevalence of diabetes,
and a lower LOI (r=−0.25; p < 0.001; n= 256). The AIS
score was not significantly correlated with the 10-year or
30-year FRS.
Impaired autonomic function (lower HRpeak) was associated
with lower SAP. Impaired HRpeak and higher SAP were
associated with increased 10-year and 30-year FRS. Impaired
HRpeak was associated with higher LOI and greater WC. Higher
SAP was associated with lower LOI, longer DOI, higher TC
and HDL-C, higher HbA1C, and higher BMI (Table 4).
We also examined whether fitness, inferred by VO2peak,
was associated with FRS scores. There were no statistically
significant correlations between VO2peak (mL · kg
−1 · min−1)
and either 10-year (r=−0.21, p= 0.80; n= 141) or 30-
year (r=−0.034, p= 0.693; n= 141) FRS.
ROC analyses were performed for each injury character-
istic and cut-points for an increased risk of CVD determined
using the derived sensitivity and specificity (Supplementary
Table 3). Individuals with a WC in excess of 95 cm, DOI > 23
years, HRpeak < 145 bpm, or SAP > 128mmHg had a higher
10-year FRS. Cut-point criteria for AIS and LOI indicate a
threshold level for increased CVD risk at C8-T2, with AIS A
completeness, but these were not statistically significant for
either 10-year or 30-year FRS. The 30-year FRS was greater
in those with a WC in excess of 94 cm, DOI > 20 years,
HRpeak < 154 bpm and SAP > 113mmHg.
Associations between CVD risk factors, FRS and
obesity in SCI
We constructed a forced multiple linear regression model to
determine the key predictors of the 10-year and 30-year
FRS (Table 5). We did not include parameters in the model
that were already incorporated in the generation of the FRS
score. Based on these analyses, the significant predictors of
an adverse 10-year and 30-year FRS were a longer DOI,
impaired autonomic function (lower HRpeak) and higher
SAP. There was a trend for a higher WC to be associated
with adverse 10-year (p= 0.058) and 30-year (p= 0.054)
FRS. LOI also tended to be associated with the 10-year FRS
(p= 0.056) and was significantly associated with the
30-year FRS (p= 0.031). Aerobic capacity tended to be
associated with the 10-year FRS (p= 0.068) but not with
the 30-year FRS (p= 0.141).
We employed AIC model-averaging to determine variable
importance in estimating 10-year and 30-year FRS. After
running 271 models for 10-year FRS, and 296 models for
30-year FRS, a larger WC, longer DOI, and higher SAP had
high variable importance (appearing in more than 80% of all
models), while a lower HRpeak, higher VO2peak and low LOI
(cat) had moderate variable importance (appearing in 60–80%
of all models) for estimating the 10-year FRS. All these
variables had high variable importance for estimating the
30-year FRS (Fig. 2) with the exception of VO2peak, which
was no longer an important predictor.
Figure 3 shows conditional inference trees for 10-year
and 30-year CVD risk. URP was employed to both deter-
mine and confirm cut-points, and independently identify
predictors of CVD risk. The identification of homogenous
subgroups is based on DOI and WC (10-year CVD risk),
and DOI, WC, and SAP (30-year CVD risk), confirming the
predictive importance of these variables (variables that do
not appear in the trees are not significant predictors). All
variables are re-entered after each split, such that a given
variable can appear multiple times in the tree. The final
nodes at the bottom show the full distribution of CVD risk
using box plots. Cut-points for DOI were similar to those
determined through ROC analyses. Cut-points for WC
based on URP depended on the DOI. For example, in
Table 2 Correlations between
markers of obesity and 10-year
and 30-year FRS.
10-year FRS (%) 30-year FRS (%)
All Male Female All Male Female






















































Bold text indicates correlations that achieved statistical significance (p < 0.05). Correlation coefficients (r),
significance levels (p), and sample sizes (n) are shown.
WC waist circumference, BMI body mass index, WHtR waist-height ratio, FRS numeric Framingham
risk score.
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individuals who had a longer DOI (>20 years) the 10-year
FRS was reduced if WC was <94 cm. However, in those
who had a shorter DOI (≤20 years), and therefore an
inherently lower CVD risk, further reduction was only seen
where WC was <80 cm.
Discussion
The main findings of this study are that measures of obesity
can be used to infer CVD risk following SCI, with WC
being the strongest obesity-related predictor for CVD risk.
Unlike BMI and WHtR, only WC was significantly asso-
ciated with both DOI and impaired cardiac autonomic
function (HRpeak). This suggests that WC may provide
additional information beyond obesity and other traditional
cardiovascular risk factors, that may play a role in the earlier
onset and faster progression of CVD following SCI [5],
such as autonomic dysfunction and specific injury char-
acteristics. This study suggests a WC cut-point for males for
an increased 10-year CVD risk following SCI of 97 cm,
which is lower than the cut-point for able-bodied males
(102 cm) [36] and reflects the higher CVD risk in this
population [5]. These results are similar to those reported by
Ravensbergen et al. [25] in a small North American cohort
of individuals with SCI. Due to a low number of females,
and in particular a low number of females “at-risk” for
CVD, a reliable cut-point for 10-year CVD risk in females
with SCI could not be determined. Accordingly, at the
present time we recommend use of the able-bodied cut-
point of 88 cm [36] to stratify CVD risk in women with
SCI, until risk profiles can be confirmed in a larger sample
of women with SCI “at-risk” for CVD. We note, however,
that this may be an overestimate of the optimal cut-point for
women with SCI in light of the reduced cut-point for males
with SCI, and the lower cut-point for the 30-year risk for
females in this study of 80 cm.
Given that WC performed as well as, or better than, BMI
and WHtR in terms of its ability to predict CVD risk, and its
known relationship to visceral adipose tissue [22] and car-
diometabolic risk [17], from a practicality standpoint we
advocate for the routine use of WC as a screening tool for
both individuals with SCI and their caregivers to consider to
assess CVD risk and guide healthy weight management. In
practical terms, when determining WC in individuals with
SCI, measurements should be conducted in the supine
position, at the narrowest part of the waist, and at the end of
a normal expiration, with a stretch-resistant measuring tape.
This is important to ensure reliable estimates of WC, and to
avoid the potential confound of flaccid paralysis of the
abdominal muscles on measurements of WC when per-
formed in the seated position. Males with a WC > 97 cm,
and females with a WC > 88 cm, should be considered at
higher risk for CVD and advised regarding risk manage-
ment strategies accordingly. While these cut-points are
useful for identifying “at-risk” individuals, WC is a mod-
ifiable factor that can be used to reduce CVD risk whether
or not the cut-point is attained. Based on this study, there is
a reduction in the FRS of ~1% for every 2–5 cm reduction
in WC, with URP analyses showing up to 75% FRS
Fig. 1 Receiver operator characteristic (ROC) curves showing the
ability of markers of obesity to predict an adverse Framingham Risk
Score. (A) Prediction of 10-year Framingham Risk Score. (B) Pre-
diction of 30-year Framingham Risk Score. The area under the curve
(AUC) for each metric is provided; a higher AUC signifies a greater
ability to correctly classify at-risk individuals. *p < 0.05 compared to
WC, Ʌp < 0.05 compared to BMI. WC waist circumference, BMI body
mass index, WHtR waist-to-height ratio.
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reduction between subgroups. Previous studies have iden-
tified a 20–25% reduction in FRS as biologically mean-
ingful [37, 38]. Individuals with an adverse risk profile
(considering both traditional and injury-related risk factors)
should be targeted for aggressive management of risk using
lifestyle modification and/or pharmacologic therapy.
A secondary aim of this study was to better understand the
CVD risk profile for individuals with SCI, including con-
sideration of unique risk parameters such as injury char-
acteristics and autonomic function, and their relationship with
CVD risk. Traditional CVD risk factors were also considered
important variables, and known traditional risk factors in the
able-bodied (smoking, presence of diabetes, adverse lipid
profiles etc.) were also pertinent risk factors for individuals
with SCI. Accordingly, smoking cessation and careful man-
agement of diabetes and lipid profiles remain important
considerations to reduce CVD risk following SCI, particularly
because individuals with SCI are at higher risk for diabetes
and metabolic syndrome [39, 40], and the proportion of
individuals with diabetes and who were smokers in this SCI
cohort was considerably higher than in a matched able-bodied
cohort [41, 42]. As in the able-bodied [43], males were at
higher risk of CVD than females, and CVD risk increased
with advancing age following SCI.
We found that a longer DOI (particularly if in excess of
~20 years) was associated with increasing CVD risk. DOI is
a covariate with age, so at the present time it is unclear
whether the relationships between DOI and CVD risk reflect
an indirect effect of advancing age on CVD risk and/or a
direct impact of a longer time living with SCI, particularly
because our recruitment criteria excluded individuals with
recent injuries. While DOI was identified as a key variable
in terms of cardiovascular risk, it is, obviously, not mod-
ifiable and so we focussed much of our attention on WC as
a modifiable parameter.
The relationship between LOI and CVD risk is complex.
There is no independent correlation between LOI and FRS.
However, we identified a threshold for CVD risk whereby
those with cervical and high-thoracic lesions tended to be at
greater risk based on ROC analyses. When data were
adjusted for other factors using regression and AIC analyses
we found an increased risk of CVD in those with low-level
lesions. Motor/sensory completeness of injury was also not
an important independent predictor of CVD risk; however,
using ROC analyses we identified a threshold for CVD risk
for those with AIS A injuries. Higher level motor/sensory
complete injuries are associated with greater decrements in
mobility and increased sedentary time, which are known to
increase CVD risk [44]. There are also reports that nutri-
tional status is further impaired in those with high-level
motor/sensory complete lesions [16], and this might also
have a negative impact on CVD risk. Indeed, those with
high-level lesions tended to have adverse HDL-C profiles.
Conversely, those with low-level lesions were more likely
to smoke and have high blood pressure, all factors that
might adversely impact risk, despite their preserved cardi-
ovascular autonomic function.
The severity of impairment to cardiovascular autonomic
function (considered in this study from the ability to
increase HR during exercise) was an important independent
factor in predicting the increased CVD burden following
SCI. One benefit of this measure is that it does not neces-
sarily require a laboratory-based exercise test for evaluation.
If an individual is able to undertake a bout of moderate-
vigorous aerobic exercise as part of their activities of daily
living, and HR increases to ~125–140 bpm, the assumption
can be made that there is at least some residual sympathetic
control of the cardiovascular system, and a decreased risk of
CVD. For individuals who complete moderate-vigorous
activity in whom HR does not exceed this threshold, the
Table 3 Correlations between markers of obesity and traditional CVD risk factors.
















































































Bold text indicates correlations that achieved statistical significance (p < 0.05). Correlation coefficients (r), significance levels (p) and sample sizes
(n) are shown. Categorical data: sex (1=male, 2= female); presence of diabetes (0= non-diabetic, 1= diabetic); smoking status (0= non-
smoker, 1= smoker).
WC waist circumference, BMI body mass index, WHtR waist-to-height ratio, SAP systolic arterial pressure, HbA1C glycated haemoglobin, HDL-C
high density lipoprotein cholesterol, TC total cholesterol.









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Evaluation of cardiovascular disease risk in individuals with chronic spinal cord injury
CVD risk can be presumed to be high, and aggressive
management of risk factors should be considered. One
question that remains unanswered is whether the increased
CVD risk associated with impaired HR regulation is a direct
effect of the loss of descending control of the cardiovascular
system, or an indirect effect of other factors known to
increase mortality that would present as a consequence of
the cardiovascular autonomic impairment, such as ortho-
static hypotension [45, 46], AD [47], arrhythmias [11], and
other vascular abnormalities [48].
The contribution of hypertension to CVD risk is typically
incorporated within the FRS; however, it is unclear if the
typical association between hypertension and CVD risk is
present following SCI, as SCI is associated with altered car-
diovascular reflex control of blood pressure [49]. Resting
hypotension may present following injury above T6, as des-
cending sympathetic pathways are compromised, and blood
pressure regulation is impaired. In the able-bodied, lower SAP
is protective against CVD risk [29]; however, in those with
SCI, hypotension is strongly associated with susceptibility to
AD [46]. These large blood pressure swings may contribute to
impairments in cerebrovascular health and increased CVD
mortality [50] and as such, resting hypotension may not
necessarily be protective of CVD risk after SCI. In addition,
accurate representation of resting blood pressure is difficult in
individuals with SCI. Although we took care to minimise the
risk of concurrent AD during blood pressure measurements, it
is likely that some participants were experiencing AD, as
reflected by some significantly elevated SAP (>150mmHg)
recordings in individuals with lesions above T6 (n= 33).
Conversely, because we measured blood pressure in the
seated position, and because of the high incidence of OH in
individuals with SCI, we may also have exacerbated hypo-
tensive recordings in susceptible individuals. These chal-
lenges with appropriate blood pressure determination in
individuals with SCI may unpredictably influence risk cal-
culations that utilise blood pressure metrics. Accordingly, we
used a neutral blood pressure in the determination of the FRS.
However, when we repeated our analyses using the recorded
SAP rather than a neutral value, our results were essentially
unchanged. Despite these nuances in the interpretation of
blood pressure data in individuals with SCI, we did observe
significant relationships between blood pressure abnormalities
and FRS. When incorporated as a linear scale, there was an
~1% increase in FRS for every 10mmHg increase in SAP.
Whether this represents the known association between
hypertension and CVD risk seen in the able-bodied [4], or
reflects an association between AD and CVD risk [10, 48], or
a combination of the two, cannot be determined from
this study.
It is often assumed that individuals with SCI have a high
risk for CVD because of the tendency to a more sedentary
lifestyle secondary to associated paralysis and use of a
wheelchair for mobility [18, 20]. While this may be at least
partly true, in this study low VO2peak was not independently
correlated with increased 10-year or 30-year FRS, sug-
gesting other factors play at least an equally important role
in determining CVD risk profiles. In fact, there was a trend
for higher VO2peak to be associated with increased 10-year
FRS (but not 30-year FRS) based on the regression data and
Table 5 Regression model outcomes for multivariate regression between injury characteristics, anthropometric variables and aerobic capacity and
10-year and 30-year FRS.
10-year FRS (n= 119), r= 0.604, p < 0.001 30-year FRS (n= 119), r= 0.599, p < 0.001
β (SE) 95% confidence interval p β (SE) 95% confidence interval p
Constant −10.7 (7.6) 4.35 to −25.8 0.161 −16.3 (15.8) 14.9 to −47.5 0.303
WC (cm) 0.21 (0.11) 0.43 to −0.01 0.058 0.45 (0.23) 0.91 to −0.01 0.054
BMI (kg · m2) 0.25 (0.30) 0.85 to −0.35 0.410 0.63 (0.63) 1.88 to −0.62 0.321
WHtR (cm · m−1) −27.6 (25.1) 22.1 to −77.3 0.274 −54.5 (52) 48.5 to −158 0.297
DOI (months) 0.26 (0.07) 0.40 to 0.12 <0.001 0.40 (0.15) 0.70 to 0.10 0.010
AIS 0.50 (0.62) 1.73 to −0.73 0.425 0.62 (1.28) 3.16 to −1.92 0.631
LOI 1.89 (0.98) 3.83 to −0.05 0.056 4.42 (2.02) 8.42 to 0.42 0.031
HRpeak (bpm) −0.10 (0.04) −0.02 to −0.18 0.006 −0.24 (0.08) −0.08 to −0.40 0.002
CI −1.23 (2.12) 2.97 to −5.43 0.561 −3.84 (4.38) 4.84 to −12.5 0.383
SAP (mmHg) 0.07 (0.03) 0.13 to 0.01 0.025 0.16 (0.06) 0.29 to 0.04 0.016
VO2peak (ml.min.kg) 0.21 (0.11) 0.43 to −0.01 0.068 0.35 (0.23) 0.81 to −0.11 0.141
Bold text indicates variables that were statistically significant contributors to the FRS. Sample sizes (n), beta coefficients (β), standard errors (SE),
and significance levels (p) are shown.
WC waist circumference, BMI body mass index, WHtR waist-to-height ratio, DOI duration of injury, AIS ordinal (considered as numeric) ASIA
impairment scale (A= 1, B= 2, C= 3, D= 4), LOI level of injury categorised as high (1, C1–C8), mid (2, T1–T6), low (3, below T6), HRpeak
maximum heart rate at peak aerobic capacity, CI chronotropic incompetence categorised as present (1) or absent (0), SAP systolic arterial pressure
incorporated as a linear variable, VO2peak peak oxygen uptake during maximal exercise, FRS numeric Framingham risk score.
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AIC analyses. Why individuals with greater aerobic capa-
city would tend to be at higher risk is unclear, and chal-
lenges our assumptions about the relationships between
physical fitness, VO2peak and CVD risk after SCI. It may be
that VO2peak less strongly reflects physical activity/fitness
after SCI, where oxygen consumption is limited by other
parameters such as the ability to increase HR or ventilation
during exercise, and the active muscle mass. Of note, it was
not possible to determine VO2peak in many individuals with
high-level lesions who could not complete the exercise test,
and who would be expected to have the lowest aerobic
capacity and highest CVD risk. It is likely that this bias
would have influenced our analyses and might be one
additional factor behind the lack of association between low
VO2peak and high CVD risk. Certainly there are current
exercise guidelines [51] for the SCI population aimed at
improving aerobic capacity with the goal of improving
cardiometabolic risk, but depending on several social,
mental and physical factors, these may or may not be fea-
sible for many individuals with SCI. While there are a
myriad of benefits to regular physical activity, the efficacy
and practicality of the modification of CVD risk through
increased physical activity is uncertain at the present time.
This study considered only traumatic SCI, because of the
small number of individuals with non-traumatic SCI in the
sample, and the possibility that risk factors may not equate
equally across injury subtypes. In general, the demographic
data from this cohort compared well with known SCI sta-
tistics [2]. However, there was a larger proportion of high
LOI in this cohort compared to population averages. There
were fewer females than males, and the females in this
cohort tended to have a low cardiovascular risk profile (as is
the case in the able-bodied), limiting our ability to reliably
determine CVD risk cut-points for females and to evaluate
sex differences in CVD risk following SCI.
With any analysis approach there are strengths and
weaknesses regarding the way covariates or confounding
variables are addressed, as well as with how missing values
are handled. Some techniques are more suitable for particular
data management approaches, and in terms of dissemination
of information to different populations (clinicians, patients,
etc.) some approaches will be more intuitive. Here we con-
firmed the rigour of our results by employing several different
techniques to evaluate CVD risk factors, including more tra-
ditional correlations and regressions, to more novel AIC and
URP analyses. This multipronged approach increases our
confidence in our findings and recommendations. In parti-
cular, our analysis approaches consistently featured the
importance of WC, DOI, and autonomic control of HR for the
prediction of CVD in individuals with SCI.
We considered a number of clinical metrics that influ-
ence CVD risk; however, we did not consider the impact of
diet and nutrition on CVD risk. This is important because
WC was one of the few modifiable risk factors for indivi-
duals with SCI to target improvements in CVD risk. Future
studies should investigate the effects of dietary modification
and increased physical activity for CVD risk reduction.
Finally, although we noted medication use in our parti-
cipants, we did not adjust our analyses for medication use,
partly because we were not significantly powered to do so,
and partly because this was not a focus of our research
question. We believe this reflects the clinical reality for
Fig. 2 Akaike Information Criterion model-averaged importance
of predictors of CVD risk. WC, DOI, and SAP (considered as
numeric) were highly important predictors, with HRpeak, LOI (cat) and
VO2peak being moderately important predictors of increased CVD risk
for the 10-year FRS (A). WC, DOI, SAP, HRpeak, and LOI (cat) were
highly important predictors for the 30-year FRS (B). The horizontal
bars represent high (appears in >80% of models) and moderate
(appears in 60–80% of models) variable importance. Beta coefficients
± standard errors are provided for parameters with moderate-high
variable importance. WC waist circumference, WHtR waist-to-height
ratio, BMI body mass index, DOI duration of injury, AIS ordinal
(considered as numeric) ASIA impairment scale (A= 1, B= 2, C= 3,
D= 4), AIS (cat) ASIA impairment scale categorised as complete (1,
AIS A) or incomplete injury (0, AIS B-D), LOI numeric level of
injury, LOI (cat) level of injury categorised as a high (1, C1-C8), mid
(2, T1–T6), or low (3, below T6) injury, HRpeak maximum heart rate at
peak aerobic capacity, CI chronotropic incompetence categorised as
present (1) or absent (0), SAP numeric systolic arterial pressure, SAP
(cat) categorised as normal (0, 110–140 mmHg) or abnormal (1, <110
mmHg or >140 mmHg); VO2peak, peak oxygen uptake during maximal
exercise.
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individuals living with SCI, and the medications used in this
study were typical medications taken by individuals with
SCI (Supplementary Table 1). However, we recognise that
the use of cardiovascular medications in particular might
influence the cardiovascular risk scores.
Conclusions
These data confirm WC as a simple, practical, modifiable
measure of CVD risk following SCI. WC is also associated
with injury characteristics and impaired autonomic function.
We provide cut-points for WC, injury characteristics and
autonomic measures for preliminary identification of those
who may have an increased risk of an adverse cardiovas-
cular event, providing simple tools that may be used to
guide further evaluation and risk management. Furthermore,
WC, DOI, HRpeak, and SAP were repeatedly identified as
important variables in determining CVD risk. We propose
that, whenever possible and in addition to traditional car-
diovascular risk factors, measures of autonomic function
and WC are determined and used to create a risk profile and
guide management of CVD risk.
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